NTRA - Natera to Participate in Upcoming Investor Conferences

PR Newswire

SAN CARLOS, Calif. , Feb. 11, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin , MD, Natera's Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. Additionally, Steve Chapman , CEO, and Mike Brophy , CFO, will participate in a fireside chat at the 10 ^th Annual SVB Leerink Global Healthcare Conference.

Details are as follows:

Access to the live webcasts will be available at investor.natera.com .

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas . It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com . Follow Natera on LinkedIn .

Contacts

Investor Relations: Mike Brophy , CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland , VP of Corporate Marketing, Natera, Inc., pr@natera.com

SOURCE Natera, Inc.